Ensysce Biosciences COO Jeffrey Millard resigns
ENSC•Chief operating officer resigns
- Ensysce Biosciences received the resignation of Chief Operating Officer Jeffrey Millard, effective July 10, 2026.
Related News
Hershey Trust Co, trustee for Milton Hershey School, sells 29,960 Hershey shares for $5.17 million
HSY•
Analysis-SpaceX's slide below IPO price risks turning blockbuster IPO into confidence test
SPCX•
United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $5,008,396.54
UTHR•
Hyatt’s JdV brand opens 197-room Lowline Hotel in downtown Charleston
H•
Great Southern Bancorp Q2 EPS USD 1.43
GSBC•